ENVALITH
株式会社リニカル logo

Linical Co., Ltd.

2183Standard MarketServices

株式会社リニカル logo
Linical Co., Ltd.2183
Reference Indicators

Market Cap

51¥100M

P/E (Forecast)

26.1x

P/B

1.2x

Dividend Yield (Forecast)

3.85%

ROE

-59.3%

EV/EBITDA

Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
11,55512,51612,30710,4378,665
Cost of Sales
7,9438,3558,5298,0617,541
Gross Profit
3,6114,1613,7782,3751,123
SG&A Expenses
2,5252,9053,0522,9593,197
Operating Income
1,0851,256725-583-2,073
Non-operating Income
1125794102114
Non-operating Expenses
1530301764
Ordinary Income
1,1831,283790-498-2,023
Extraordinary Income
16215137
Extraordinary Losses
3135616614990
Pre-tax Income
1,0311,378660-512-3,013
Income Taxes
24137432126316
Net Income
7901,004338-539-3,329
EBITDA
1,5261,7561,243-51-1,561
Gross Margin
31.3%33.2%30.7%22.8%13.0%
Operating Margin
9.4%10.0%5.9%-5.6%-23.9%
ROA
5.0%5.8%1.8%-3.2%-27.7%
ROE
12.9%14.2%4.3%-7.0%-59.3%